These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 18443739)

  • 21. Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats.
    Tran TM; Dorris ML; Satumtira N; Richardson JA; Hammer RE; Shang J; Taurog JD
    Arthritis Rheum; 2006 Apr; 54(4):1317-27. PubMed ID: 16575857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta 2-microglobulin amyloid deposit in HLA-B27 transgenic rats.
    Fukunishi S; Yoh K; Kamae S; Yoshiya S
    Mod Rheumatol; 2007; 17(5):380-4. PubMed ID: 17929129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenetic basis of the seronegative spondyloarthropathies.
    Ivanyi P
    Curr Opin Rheumatol; 1992 Aug; 4(4):484-93. PubMed ID: 1503871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and dynamic features of HLA-B27 subtypes.
    Uchanska-Ziegler B; Ziegler A; Schmieder P
    Curr Opin Rheumatol; 2013 Jul; 25(4):411-8. PubMed ID: 23673483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic rats.
    Lin P; Bach M; Asquith M; Lee AY; Akileswaran L; Stauffer P; Davin S; Pan Y; Cambronne ED; Dorris M; Debelius JW; Lauber CL; Ackermann G; Baeza YV; Gill T; Knight R; Colbert RA; Taurog JD; Van Gelder RN; Rosenbaum JT
    PLoS One; 2014; 9(8):e105684. PubMed ID: 25140823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-B27 and antigen presentation: at the crossroads between immune defense and autoimmunity.
    Sorrentino R; Böckmann RA; Fiorillo MT
    Mol Immunol; 2014 Jan; 57(1):22-7. PubMed ID: 23916069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-B27 misfolding and spondyloarthropathies: not so groovy after all?
    Colbert RA
    J Rheumatol; 2000 May; 27(5):1107-9. PubMed ID: 10813272
    [No Abstract]   [Full Text] [Related]  

  • 28. [An interview with Alan Ebringer. What is going to happen tomorrow concerning HLA-B27 and ankylosing spondylathritis?. Interview by P. Youinou].
    Ebringer A
    Ann Med Interne (Paris); 1994; 145(4):238-40. PubMed ID: 8092648
    [No Abstract]   [Full Text] [Related]  

  • 29. An overview of clinical spectrum and heterogeneity of spondyloarthropathies.
    Khan MA
    Rheum Dis Clin North Am; 1992 Feb; 18(1):1-10. PubMed ID: 1561395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ankylosing spondylitis, HLA B27, and beyond.
    Nuki G
    Lancet; 1998 Mar; 351(9105):767-9. PubMed ID: 9519942
    [No Abstract]   [Full Text] [Related]  

  • 31. The pathogenetic role of HLA-B27 and its subtypes.
    Khan MA; Mathieu A; Sorrentino R; Akkoc N
    Autoimmun Rev; 2007 Jan; 6(3):183-9. PubMed ID: 17289555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HLA-B27 in Bechterew's disease].
    Ulvestad E
    Tidsskr Nor Laegeforen; 2000 Apr; 120(11):1317-22. PubMed ID: 10868094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.
    Taurog JD; Maika SD; Simmons WA; Breban M; Hammer RE
    J Immunol; 1993 May; 150(9):4168-78. PubMed ID: 8473755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of HLA-B27 antigens in patients with dialysis-related beta 2-M amyloidosis.
    Charmes JP; Drouet M; Leroux-Robert C; Ton That H; Bouteiller G
    Clin Nephrol; 1991 Oct; 36(4):214. PubMed ID: 1959251
    [No Abstract]   [Full Text] [Related]  

  • 35. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis.
    Jaakkola E; Herzberg I; Laiho K; Barnardo MC; Pointon JJ; Kauppi M; Kaarela K; Tuomilehto-Wolf E; Tuomilehto J; Wordsworth BP; Brown MA
    Ann Rheum Dis; 2006 Jun; 65(6):775-80. PubMed ID: 16249228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [HLA-B27 polymorphism and spondyloarthropathies].
    Peixoto MJ; Gonzales T; Spinola H; Couto AR; Mora MG; Brehm A; Santos MR; Garrett F; Armas JB
    Acta Med Port; 2005; 18(4):283-93. PubMed ID: 16584661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between dendritic cell functional defect and spondylarthritis phenotypes in HLA-B27/HUMAN beta2-microglobulin-transgenic rat lines.
    Fert I; Glatigny S; Poulain C; Satumtira N; Dorris ML; Taurog JD; Breban M
    Arthritis Rheum; 2008 Nov; 58(11):3425-9. PubMed ID: 18975325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inducible nitric oxide synthase attenuates chronic colitis in human histocompatibility antigen HLA-B27/human beta2 microglobulin transgenic rats.
    Blanchard HS; Dernis-Labous E; Lamarque D; Nhieu JT; Szepes Z; Fléjou JF; Wollman E; Whittle BJ; Breban M
    Eur Cytokine Netw; 2001 Mar; 12(1):111-8. PubMed ID: 11282554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [HLA-B27 molecular subtypes and spondylarthropathies].
    Tieng V; Charron D; Toubert A
    Pathol Biol (Paris); 1998 Dec; 46(10):737-40. PubMed ID: 9922989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased levels of serum soluble HLA class I antigens in HLA-B27 positive spondyloarthropathies.
    Toussirot E; Saas P; Pariset J; Chabod J; Tiberghien P; Wendling D
    Ann Rheum Dis; 2006 Feb; 65(2):279-80. PubMed ID: 16410541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.